ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,776Medicare Part D Prescriptions Filled, Including Refills

Rank: 141 out of 783

$1.06M Total Retail Price of All Prescriptions

Rank: 42 out of 783

376 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 376 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 376 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

0% of this provider’s 7,854 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$90 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 522 348 1 3
CARVEDILOL 479 352 2 21
OMEPRAZOLE 468 306 3 6
AMLODIPINE BESYLATE 394 316 4 5
LOSARTAN POTASSIUM 368 257 5 18
LEVOTHYROXINE SODIUM 298 217 6 1
FUROSEMIDE 255 172 7 7
PRAVASTATIN SODIUM 205 183 8 14
ADVAIR DISKUS 204 90 9 50
FLUTICASONE PROPIONATE 198 126 10 46
METFORMIN HCL 193 108 11 8
SPIRIVA 192 82 12 59
TAMSULOSIN HCL 185 129 13 26
LISINOPRIL 172 132 14 4
TRAMADOL HCL-ACETAMINOPHEN 168 129 15 167
FAMOTIDINE 162 86 16 55
ALLOPURINOL 153 137 17 31
POLYETHYLENE GLYCOL 3350 147 72 18 43
NAMENDA 135 135 19 32
TORSEMIDE 129 79 20 126
JANUVIA 127 88 21 73
CRESTOR 122 70 22 27
DONEPEZIL HCL 119 119 23 24
GABAPENTIN 118 76 24 15
CITALOPRAM HBR 111 69 25 19
MELOXICAM 111 59 25 37
GLIMEPIRIDE 109 90 27 34
ZOLPIDEM TARTRATE 107 78 28 23
METOPROLOL SUCCINATE 105 55 29 13
TRAMADOL HCL 103 82 30 20
CLOPIDOGREL 100 73 31 29
SPIRONOLACTONE 97 68 32 57
OXYBUTYNIN CHLORIDE ER 90 45 33 117
KLOR-CON M20 89 50 34 48
RANITIDINE HCL 89 38 34 44
POTASSIUM CHLORIDE 88 47 36 16
ATORVASTATIN CALCIUM 85 62 37 11
PEN NEEDLE 78 49 38 103
PLAVIX 73 51 39 51
BUMETANIDE 73 69 39 131
LOSARTAN-HYDROCHLOROTHIAZIDE 71 51 41 53
NOVOLOG 68 60 42 81
ISOSORBIDE MONONITRATE ER 67 47 43 40
AMLODIPINE BESYLATE-BENAZEPRIL 64 42 44 83
CYMBALTA 62 30 45 35
LOVAZA 61 49 46 163
METOPROLOL TARTRATE 60 40 47 9
PANTOPRAZOLE SODIUM 60 48 47 30
FINASTERIDE 60 57 47 127
ALENDRONATE SODIUM 59 48 50 25
TRAZODONE HCL 58 0 51 39
OXYBUTYNIN CHLORIDE 57 35 52 96
HYDROCODONE-ACETAMINOPHEN 57 45 S3 52 2
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 30 54 33
RISPERIDONE 56 41 54 67
LANTUS SOLOSTAR 54 21 56 91
NAPROXEN 54 24 56 104
WARFARIN SODIUM 53 24 58 10
LEVETIRACETAM 52 26 59 89
MIRTAZAPINE 51 47 60 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 24, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.